All In Biotech

Drug Trial Radar · NCT03199560

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

A Randomized Controlled Double-blinded Study Comparing the Intraoperative Injection of Lymphatic Mapping Agents Tc 99m Tilmanocept to Tc 99m Filtered Sulfur Colloid in Breast Cancer Patients Undergoing Breast Conservation and Sentinel Lymph Node Biopsy

Last checked: Nov 20, 2026Latest source record: Aug 24, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

86

Planned (sponsor's estimate)

Start

Jun 22, 2017

Primary completion

Jun 22, 2019

Study completion Aug 22, 2019

Sponsor

Lead sponsor
Memorial Health University Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 27, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized controlled double-blinded study comparing the intraoperative injection of lymphatic mapping agents Tc 99m tilmanocept to Tc 99m filtered sulfur colloid in breast cancer patients undergoing breast conservation and sentinel lymph node biopsy

Conditions

  • Sentinel Lymph Node Biopsy
  • Breast Cancer

Interventions

  • Tc 99m tilmanoceptDrug

    lymphatic mapping agent

  • Tc 99m filtered sulfur colloidDrug

    lymphatic mapping agent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of harvested lymph nodesTime frame: 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Memorial Health University Medical Center

    Savannah, Georgia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.